Latest Breaking News On - Biopharma sub inc - Page 1 : comparemela.com

AEON Biopharma Reports First Quarter 2024 Financial Results

AEON Biopharma Reports First Quarter 2024 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCorey davisDrug administrationDaewoong pharmaceutical coEuropean unionEuropean medicines agencyHealth canadaExchange commissionCompany phaseBiopharma incCompany board of directors as daewoongBiopharma sub incReports first quarterMarc forthChief executive

AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results

AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCorey davisEuropean medicines agencyBiopharma incDaewoong pharmaceutical coHealth canadaEuropean unionDrug administrationBiopharma sub incEpisodic migraine program nextExchange commissionReports fourth quarterFull yearMarc forthChief executive

AEON Biopharma Reports Third Quarter 2023 Financial Results - AEON Biopharma (AMEX:AEON)

– Announced topline results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the preventive treatment of episodic migraine that support advancing the program into a pivotal Phase 3 study – – Ongoing Phase 2

United statesUnited kingdomCorey davisBiopharma incHealth canadaEuropean unionDrug administrationExchange commissionInternational parkinsonEuropean medicines agencyBiopharma sub incEpisodic migraine program nextPriveterra acquisition corpTrademark officeMovement disorders society congressOngoing phase